COVID-19 Spike RBD and Membrane Protein Human IgG ELISA Assay |
MBS412772-48AntigenWells48ControlAntigenWells |
MyBiosource |
48AntigenWells&48ControlAntigenWells |
EUR 635 |
Human IgG antibody Laboratories manufactures the ace2 spike protein stoichometry reagents distributed by Genprice. The Ace2 Spike Protein Stoichometry reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike Protein. Other Ace2 products are available in stock. Specificity: Ace2 Category: Spike Group: Protein Stoichometry
Protein Stoichometry information
Spike S1 Protein-His |
MBS8574739-01mg |
MyBiosource |
0.1mg |
EUR 705 |
Spike S1 Protein-His |
MBS8574739-5x01mg |
MyBiosource |
5x0.1mg |
EUR 2910 |
MERS Spike Protein RBD |
MBS515779-001mg |
MyBiosource |
0.01mg |
EUR 225 |
MERS Spike Protein RBD |
MBS515779-002mg |
MyBiosource |
0.02mg |
EUR 290 |
MERS Spike Protein RBD |
MBS515779-005mg |
MyBiosource |
0.05mg |
EUR 365 |
MERS Spike Protein RBD |
MBS515779-01mg |
MyBiosource |
0.1mg |
EUR 495 |
MERS Spike Protein RBD |
MBS515779-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1965 |
Spike S1 (B.1.1.7; Alpha Variant) (SARS-CoV-2): ACE2 TR-FRET Assay Kit |
78282 |
BPS Bioscience |
384 rxns. |
EUR 930 |
Description: The Spike S1 (B.1.1.7; Alpha Variant) (SARS-CoV-2): ACE2 TR-FRET Assay is designed to measure the inhibition of the binding between SARS-CoV-2 Spike S1 (B.1.1.7; Alpha Variant) and human ACE2 in a homogeneous 384 reaction format. This TR-FRET-based assay requires no time-consuming washing steps, making it especially suitable for high throughput screening applications. The assay procedure is straightforward and simple; the test inhibitor compound is incubated with biotinylated Spike S1, Eu-labeled ACE2, and dye-labeled acceptor for one hour. Then the TR-FRET signal is measured using a fluorescence reader capable of measuring Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET). |
Spike S1 (P.1; Gamma Variant) (SARS-CoV-2): ACE2 TR-FRET Assay Kit |
78284 |
BPS Bioscience |
384 rxns. |
EUR 1070 |
Description: The Spike S1 (P.1; Gamma Variant) (SARS-CoV-2): ACE2 TR-FRET Assay is designed to measure the inhibition of the binding between Spike S1 (P.1) (SARS-CoV-2) and human ACE2 in a homogeneous 384 reaction format. This TR-FRET-based assay requires no time-consuming washing steps, making it especially suitable for high throughput screening applications. The assay procedure is straightforward and simple; the test inhibitor compound is incubated with biotinylated Spike S1, Eu-labeled ACE2, and the dye-labeled acceptor for one hour. Then the TR-FRET signal is measured using a fluorescence reader capable of measuring Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET). |
SARS-CoV Spike Protein |
abx060655-1mg |
Abbexa |
1 mg |
EUR 2030.4 |
|
SARS-CoV Spike Protein |
abx060655-100g |
Abbexa |
100 µg |
Ask for price |
SARS-CoV Spike Protein |
abx060655-10g |
Abbexa |
10 µg |
EUR 1962.5 |
SARS-CoV Spike Protein |
abx060655-50g |
Abbexa |
50 µg |
Ask for price |
SARS-CoV Spike Protein |
abx060656-100g |
Abbexa |
100 µg |
Ask for price |
SARS-CoV Spike Protein |
abx060656-10g |
Abbexa |
10 µg |
EUR 1962.5 |
SARS-CoV Spike Protein |
abx060656-50g |
Abbexa |
50 µg |
Ask for price |
SARS-CoV Spike Protein |
abx060657-100g |
Abbexa |
100 µg |
Ask for price |